These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 17105921

  • 1. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs.
    Rothman RB, Baumann MH.
    Ann N Y Acad Sci; 2006 Aug; 1074():245-60. PubMed ID: 17105921
    [Abstract] [Full Text] [Related]

  • 2. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.
    Rothman RB, Blough BE, Baumann MH.
    AAPS J; 2007 Jan 05; 9(1):E1-10. PubMed ID: 17408232
    [Abstract] [Full Text] [Related]

  • 3. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
    Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, Baumann MH.
    J Pharmacol Exp Ther; 2005 Jun 05; 313(3):1361-9. PubMed ID: 15761112
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.
    Rothman RB, Blough BE, Baumann MH.
    Exp Clin Psychopharmacol; 2008 Dec 05; 16(6):458-74. PubMed ID: 19086767
    [Abstract] [Full Text] [Related]

  • 6. Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys.
    Negus SS, Mello NK, Blough BE, Baumann MH, Rothman RB.
    J Pharmacol Exp Ther; 2007 Feb 05; 320(2):627-36. PubMed ID: 17071819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Appetite suppressants as agonist substitution therapies for stimulant dependence.
    Rothman RB, Blough BE, Baumann MH.
    Ann N Y Acad Sci; 2002 Jun 05; 965():109-26. PubMed ID: 12105089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
    Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS.
    Synapse; 2001 Jan 05; 39(1):32-41. PubMed ID: 11071707
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
    Banks ML, Bauer CT, Blough BE, Rothman RB, Partilla JS, Baumann MH, Negus SS.
    Exp Clin Psychopharmacol; 2014 Jun 05; 22(3):274-284. PubMed ID: 24796848
    [Abstract] [Full Text] [Related]

  • 13. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
    Rothman RB, Blough BE, Baumann MH.
    Trends Pharmacol Sci; 2006 Dec 05; 27(12):612-8. PubMed ID: 17056126
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats.
    Pum M, Carey RJ, Huston JP, Müller CP.
    Psychopharmacology (Berl); 2007 Aug 05; 193(3):375-90. PubMed ID: 17468969
    [Abstract] [Full Text] [Related]

  • 17. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB.
    Ann N Y Acad Sci; 2004 Oct 05; 1025():189-97. PubMed ID: 15542717
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens.
    Heidbreder C, Feldon J.
    Synapse; 1998 Aug 05; 29(4):310-22. PubMed ID: 9661249
    [Abstract] [Full Text] [Related]

  • 20. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S, De Deurwaerdère P, Porras G, Spampinato U.
    Neuropsychopharmacology; 2004 Feb 05; 29(2):319-26. PubMed ID: 14560323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.